Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corcept Therapeutics (CORT) Depreciation & Amortization (CF) (2016 - 2026)

Corcept Therapeutics (CORT) has disclosed Depreciation & Amortization (CF) for 15 consecutive years, with $598000.0 as the latest value for Q1 2026.

  • For Q1 2026, Depreciation & Amortization (CF) rose 29.44% year-over-year to $598000.0; the TTM value through Mar 2026 reached $1.3 million, up 13.02%, while the annual FY2025 figure was $1.1 million, 44.53% up from the prior year.
  • Depreciation & Amortization (CF) hit $598000.0 in Q1 2026 for Corcept Therapeutics, up from $289000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $660000.0 in Q4 2022 and bottomed at $76000.0 in Q2 2024.
  • Average Depreciation & Amortization (CF) over 5 years is $284882.4, with a median of $281000.0 recorded in 2024.
  • Year-over-year, Depreciation & Amortization (CF) plummeted 94.77% in 2022 and then soared 285.0% in 2025.
  • Corcept Therapeutics' Depreciation & Amortization (CF) stood at $660000.0 in 2022, then plummeted by 67.58% to $214000.0 in 2023, then soared by 31.31% to $281000.0 in 2024, then rose by 2.85% to $289000.0 in 2025, then skyrocketed by 106.92% to $598000.0 in 2026.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods came in at $598000.0, $289000.0, and $289000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.